SynHelix (now Quantoom Biosciences, a Univercells Company)
Created in 2019
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
664 8,234Activities
Technologies
Entity types
Location
4 Rue Pierre Fontaine, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 11-50, 51-200
Estimated: 122
SIREN
848917373Engaged corporates
2
2 1Added in Motherbase
1 year, 3 months ago
biotech Value proposition
Large-scale DNA synthesis technology that harnesses natural enzymes.
Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.
Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnologyOriginal language
Large-scale DNA synthesis technology that harnesses natural enzymes.
Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.
mRNA production reinvented • Quantoom
By reinventing mRNA production, we remove barriers to manufacturing mRNA-based vaccines and therapeutics from R&D up to mass production
https://quantoom.com/
